Guillaume Bernadat

Dr. Guillaume Bernadat

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2017 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
JMJérémy Merad
Jérémy Merad
CLClaudia Lalli
Claudia Lalli
GBGuillaume Bernadat
Guillaume Bernadat
JMJulien Maury
Julien Maury
GMGéraldine Masson
Géraldine Masson

27 February 2017 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
DLDavid Lachkar
David Lachkar
NDNatacha Denizot
Natacha Denizot
GBGuillaume Bernadat
Guillaume Bernadat
KAKadiria Ahamada
Kadiria Ahamada
MBMehdi Beniddir
Mehdi Beniddir
GVGuillaume Vincent
Guillaume Vincent

11 September 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JPJonathan Pous
Jonathan Pous
TCThibaut Courant
Thibaut Courant
GBGuillaume Bernadat
Guillaume Bernadat
BIBogdan Iorga
Bogdan Iorga
FBFlorent Blanchard
Florent Blanchard
GMGéraldine Masson
Géraldine Masson

6 November 2014 in Synlett
Verified
Journal Article
Closed access
PDF file
GMGeraldine Masson
Geraldine Masson
GBGuillaume Bernadat
Guillaume Bernadat
As demonstrated by earlier successes with enamines, nitrogen-activated C=C double bonds have considerable potential for use in the construction of various nitrogen-containing products. To expand the applications of this class of substrates, we focused on studying the reactivity of enamides and enecarbamates as promising representatives. Starting from the well-known Povarov reaction, we gradually developed other cycloaddition reactions and, more generally, an extended range of methods for α,β-difunctionalization. Our most recent work, which involves radical processes, has contributed to a significant increase in the diversity of scaffolds accessible from these nitrogenous substrates and is potentially applicable to various natural and bioactive synthetic targets. 1 Introduction 2 General Design 3 Asymmetric Brønsted Acid-Catalyzed α,β-Difunctionalization of Enamides 3.1 Intramolecular α,β-Difunctionalization of Enamides Through Cycloaddition Reactions 3.1.1 Povarov Reactions 3.1.2 Diels–Alder Reactions of 1-Azadienes 3.2 Intermolecular α,β-Difunctionalization of Enamides 3.2.1 Mannich Reactions 3.2.2 Addition to Azo Compounds 3.2.3 Halogenation Reactions 4 Radical Tandem Difunctionalization: β-Alkylation Followed by α-Functionalization of Enamides 4.1 Photoredox-Mediated Tandem α,β-Difunctionalization of Enamides 4.1.1 Oxyalkylation 4.1.2 Oxy-, Amino- and Carbotrifluoromethylation 4.2 Single-Electron Transfer-Mediated Tandem α,β-Difunctionalization of Enamides 5 Conclusion

1 February 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IKIlhem Khelifi
Ilhem Khelifi
TNTimothée Naret
Timothée Naret
DRDolor Renko
Dolor Renko
AHAbdallah Hamze
Abdallah Hamze
GBGuillaume Bernadat
Guillaume Bernadat
MAMouad Alami
Mouad Alami

19 September 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
JAJessy Aziz
Jessy Aziz
EBEtienne Brachet
Etienne Brachet
Abdallah HamzeAbdallah Hamze
Abdallah Hamze
JPJean-François Peyrat
Jean-François Peyrat
GBGuillaume Bernadat
Guillaume Bernadat
MAMouad Alami
Mouad Alami
The synthesis and structure–activity relationships associated with a series of 1,1-diarylethylene tubulin polymerization inhibitors 3 and 4 are described. The key step for their preparation involves a palladium-catalyzed coupling of N-arylsulfonylhydrazones with aryl halides, thus providing flexible and convergent access to tri- and tetrasubstituted 1,1-diarylolefins 3 and 4 related to isocombretastatin A-4 (isoCA-4). These compounds have been evaluated for tubulin polymerization inhibitory activity as well as for cytotoxic activity. The most potent compounds are 1,1-diaryl-2-methoxyethylenes 4b, 4d and 4e having a trisubstituted double bond. They exhibited good antiproliferative activity against various human cancer cell lines (GI50 = 8–80 nM). Compounds 4b and 4e strongly inhibited tubulin polymerization with IC50 values of 2 and 3 μM, respectively, and induced cell cycle arrest in the G2/M phase in the K562 cell line. Docking studies in the colchicine binding site of tubulin allowed identification of residues most likely to interact with these inhibitors and explain their potent anti-tubulin activity.